Thymidine Kinase 2 Deficiency Treatment Market
Jun 09, 2025
Thymidine Kinase 2 Deficiency Treatment: Advances in Therapeutic Strategies and Clinical Development
Thymidine kinase 2 deficiency (TK2d) is a rare and life-threatening genetic condition and a type of mitochondrial disease. It stems from mutations in the TK2 gene, which is essential for the replication of mitochondrial DNA (mtDNA). These mutations lead to a depletion of mtDNA, resulting in profound muscle weakness...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
